PDF(Pubmed)
Abstract：
Ceftriaxone, a regularly used antibiotic for broad-spectrum coverage, is a rare cause of hemolytic anemia. Patients may present with truncal pain, nausea, vomiting, and an acute drop in hemoglobin within 48 hours of administration. Prompt recognition and initiation of treatment are essential. We describe a case of a 65-year-old woman being treated for osteomyelitis who developed hemolytic anemia, disseminated intravascular coagulation, and multi-system organ failure after being de-escalated from cefepime to ceftriaxone.
摘要：
头孢曲松,一种广谱的常用抗生素，是溶血性贫血的罕见原因.患者可能会出现躯干疼痛，恶心,呕吐,在给药后48小时内血红蛋白出现急性下降。及时识别和开始治疗至关重要。我们描述了一个65岁的女性正在接受骨髓炎治疗的案例，该女性患有溶血性贫血，弥散性血管内凝血,从头孢吡肟降级为头孢曲松后出现多系统器官衰竭。
